Purchase Order 75N93020P00940
- Not listed
- This is a $14,500.00 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC. The contract is for an RT PCR System and does not have a set-aside designation. Qiagen, LLC is a subsidiary of the larger Qiagen N.V. corporation, an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has a history...
- Qiagen, LLC has been awarded a firm fixed price purchase order totaling $18,780.30 by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for an annual service agreement to provide support for Qiagen's QIAcuity Eight Digital PCR System in Bethesda, Maryland through February 27, 2025. No set-aside designation was used for this award to support the agency's research into allergies and infectious...
- This is a firm fixed-price purchase order awarded to Qiagen, LLC by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $16,101.84 and a period of performance through May 11, 2024. The award does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V. Qiagen provides a range of products and services to support federal...
- This $28,400 firm fixed price purchase order was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Qiagen, LLC, a division of the international provider Qiagen N.V. The agency procured the QIASTAT-DX ANALYZER, a real-time PCR system for detecting pathogen nucleic acids in human samples, with a completion date of September 30, 2019. No set-aside designations were used, and the award was made under a full...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC for a full service agreement on QIAXTRACTOR/QIACUBE HT systems. The contract has a ceiling value of $10,698.00 and a period of performance through April 30, 2022. Qiagen, LLC is a division of the parent company Qiagen N.V., which is an international provider of sample and assay technologies...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC for the provision of custom PCR arrays and reagents. The award has a ceiling value of $4,324.80 and a completion date of June 30, 2016. Qiagen, LLC is a subsidiary of the international biotechnology company Qiagen N.V., which has a history of providing specialized products and services to support...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for a PCR system on March 19, 2020, with a ceiling value of $16,503.50 and ultimate completion date of April 16, 2020. Performance took place in Germantown, Maryland. The order was priced on a firm fixed-price basis with no set-aside applied.</p>
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Qiagen, LLC for a TISSUELYSER II system. The total ceiling value of the contract is $14,003.22, with a completion date of September 28, 2022. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which provides a wide range of sample and assay technologies to support federal agencies'...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $44,005 purchase order to Qiagen, LLC to procure a QIACUITY ONE, 5PLEX digital PCR system with trade in of a RainDrop digital PCR system. Qiagen, LLC will deliver the requested products and services under a firm fixed price contract running from April 15, 2022 through May 31, 2022. As the parent company, Qiagen N.V. ultimately benefits from this contract to supply...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Qiagen, LLC for the delivery of RT-PCR kits for gene expression. The contract has a total ceiling value of $12,154.52 and a completion date of February 18, 2015. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which provides a wide range of sample and assay...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Qiagen, LLC for a QIAcuity Four Platform System, which is a digital PCR system. The contract was awarded on July 22, 2020 with a ceiling value of $110,846.00 and a completion date of July 22, 2021. The system includes a PCR instrument, laptop, software, and other accessories. The award was not set aside for any specific business type. Qiagen, LLC is a division of the parent company Qiagen N.V., which is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and subcontractor awards.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
PCR System | RFQ-RML-E-2030995 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 7/9/20, 3:56 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $110.8k | 7/22/20 |